Screener
Lexicon Pharmaceuticals LXRX PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Assets | As of June 30, 2026 / (unaudited) | As of December 31, 2025 |
|---|---|---|
| Inventory | 1,196 | 281 |
| Prepaid expenses and other current assets | 3,128 | 3,000 |
| Total current assets | 196,577 | 101,895 |
| Property and equipment, net | 1,651 | 1,863 |
| Goodwill | 44,543 | 44,543 |
| Operating lease right-of-use-assets | 6,921 | 7,318 |
| Restricted cash | — | 29,000 |
| Other assets | 368 | 368 |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's PP&E (net)?
- Lexicon Pharmaceuticals (LXRX) reported PP&E (net) of $1.65M in Q2 2026.
- How has Lexicon Pharmaceuticals's PP&E (net) changed year-over-year?
- Lexicon Pharmaceuticals's PP&E (net) decreased by 22.6% year-over-year, from $2.13M to $1.65M.
- What is the long-term trend for Lexicon Pharmaceuticals's PP&E (net)?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's PP&E (net) has grown at a 44.6% compound annual growth rate (CAGR), from $295K to $1.86M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Lexicon Pharmaceuticals's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude